The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
The NICE Cost-Effectiveness Threshold: What it is and What that Means
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Institute for Clinical Excellence and its value judgments
Rawlins, M. D., & Culyer, A. J. (2004) · BMJ · doi:10.1136/bmj.329.7459.224 · Cited by 765
Self-citationDevlin, N., & Parkin, D. (2004) · Health Economics · doi:10.1002/hec.864 · Cited by 709
QALY maximisation and people's preferences: a methodological review of the literature
Dolan, P., Shaw, R., Tsuchiya, A., & Williams, A. (2005) · Health Economics · doi:10.1002/hec.924 · Cited by 431
Cost effectiveness/utility analyses
Birch, S., & Gafni, A. (1992) · Journal of Health Economics · doi:10.1016/0167-6296(92)90004-k · Cited by 275
Value based pricing for NHS drugs: an opportunity not to be missed?
Claxton, K., Briggs, A., Buxton, M. J., Culyer, A. J., McCabe, C., Walker, S., & Sculpher, M. J. (2008) · BMJ · doi:10.1136/bmj.39434.500185.25 · Cited by 230
Self-citationGafni, A., & Birch, S. (1993) · Europe PMC (PubMed Central) · Cited by 175
Culyer, A., McCabe, C., Briggs, A., Claxton, K., Buxton, M., Akehurst, R., Sculpher, M., & Brazier, J. (2007) · Journal of Health Services Research & Policy · doi:10.1258/135581907779497567 · Cited by 173
Self-citationOpportunity costs and uncertainty in the economic evaluation of health care interventions
Sendi, P., Gafni, A., & Birch, S. (2002) · Health Economics · doi:10.1002/hec.641 · Cited by 115
Discounting and cost‐effectiveness in NICE – stepping back to sort out a confusion
Claxton, K., Sculpher, M., Culyer, A. J., McCabe, C. J., Briggs, A. H., Akehurst, R. L., Buxton, M. J., & Brazier, J. E. (2005) · Health Economics · doi:10.1002/hec.1081 · Cited by 103
Self-citationOn being NICE in the UK: guidelines for technology appraisal for the NHS in England and Wales
Birch, S., & Gafni, A. (2002) · Health Economics · doi:10.1002/hec.706 · Cited by 69
Cited by
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Claxton, K., Martin, S., Soares, M., Rice, N., Spackman, E., Hinde, S., Devlin, N., Smith, P. C., & Sculpher, M. (2015) · Health Technology Assessment · doi:10.3310/hta19140 · Cited by 853
Self-citationLong-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
Caraceni, P., Riggio, O., Angeli, P., Alessandria, C., Neri, S., Foschi, F. G., Levantesi, F., Airoldi, A., Boccia, S., Svegliati-Baroni, G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30840-7 · Cited by 536
Clark, F., Jackson, J., Carlson, M., Chou, C.-P., Cherry, B. J., Jordan-Marsh, M., Knight, B. G., Mandel, D., Blanchard, J., Granger, D. A., et al. (2012) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2009.099754 · Cited by 445
The cost-effectiveness of digital health interventions: A systematic review of the literature
Gentili, A., Failla, G., Melnyk, A., Puleo, V., Tanna, G. L. D., Ricciardi, W., & Cascini, F. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.787135 · Cited by 444
Metadata
- Authors
- McCabe, C., Claxton, K., & Culyer, A. J.
- Venue
- PharmacoEconomics
- Published
- 2008
- Volume
- 26
- Issue
- 9
- Pages
- 733-744
- ISSN
- 1170-7690 (ISSN-L)
- OpenAlex
- W2010913334
- Cited by
- 864
- References
- 13
- FWCI
- 65.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The NICE Cost-Effectiveness Threshold: What it is and What that Means. https://app.cochat.ai/papers/10.2165/00019053-200826090-00004
- The paper
- McCabe, C., Claxton, K., & Culyer, A. J. (2008). The NICE Cost-Effectiveness Threshold: What it is and What that Means. PharmacoEconomics. https://doi.org/10.2165/00019053-200826090-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.